Get it while you can, big drug companies! Pharmaceutical giants like Pfizer Inc, AstraZeneca and Bristol Meyers Squibb are feeling a little panicky as the deadlines loom on patents for some of their best-selling drugs, so what do they do? Up the prices now, before those pesky generic versions arrive to drive consumer costs down.
bristol meyers squibb
By March 30, 2011